Current Neuro-Oncology
Volume
23 Number 9
15 May 2021
Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 9, 15 May
Huang
WY, Wen LH, Wu G, Pang PP, Ogbuji R, Zhang CC, Chen F, Zhao
JN.
Radiological
model based on the standard magnetic resonance sequences for
detecting methylguanine methyltransferase methylation in glioma
using texture analysis.
Cancer
Sci. 2021 May 1∟.
doi: 10.1111/cas.14918∟.
PMID: 33932065∟.
Observational study. ˍ
*
Kheiri
G, Habibi Z, Nejat F.
Spontaneous
regression of congenital brain tumors: a report of two
cases.
Childs
Nerv Syst. 2021 May 1∟.
doi: 10.1007/s00381-021-05172-1∟.
PMID: 33934203∟.
Case report. ˍ
*
Weller
J, Katzendobler S, Karschnia P, Lietke S, Egensperger R, Thon N,
Weller M, Suchorska B, Tonn JC.
PCV
chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged
disease control with low risk of malignant progression.
J
Neurooncol. 2021 May 1∟.
doi: 10.1007/s11060-021-03765-z∟.
PMID: 33932195∟.
Observational study. ˍ
Likar
R, Koestenberger M, Stutschnig M, Nahler G.
Cannabidiol
Μay Prolong
Survival
in Patients With Glioblastoma Multiforme.
Cancer
Diagn Progn. 2021 May 3, 2021;1(2):77-82∟.
doi: 10.21873/cdp.10011∟.
PMID: 35403130∟.
Observational study. ˍ
Ronsley
R, Hounjet CD, Cheng S, Rassekh SR, Duncan WJ, Dunham C, Gardiner
J, Ghag A, Ludemann JP, Wensley D, Rehmus W, Sargent MA, Hukin
J.
Trametinib
therapy for children with neurofibromatosis type 1 and
life-threatening plexiform neurofibroma or treatment-refractory
low-grade glioma.
Cancer
Med. 2021 May 3, 2021;10(11):3556-3564∟.
doi: 10.1002/cam4.3910∟.
PMID: 33939292∟.
Case report. ˍ
Lin
NU, Pegram M, Sahebjam S, Ibrahim N, Fung A, Cheng A, Nicholas A,
Kirschbrown W, Kumthekar P.
Pertuzumab
Plus High-Dose Trastuzumab in Patients With Progressive Brain
Metastases and HER2-Positive Metastatic Breast Cancer: Primary
Analysis of a Phase II Study.
J
Clin Oncol. 2021 May 4, 2021;39(24):2667-2675∟.
doi: 10.1200/JCO.20.02822∟.
PMID: 33945296∟.
Interventional study. ˍ
Cao
L, Rong P, Zhu G, Xu A, Chen S.
Clinical
Characteristics and Overall Survival Prognostic Nomogram for
Oligodendroglioma: A Surveillance, Epidemiology, and End Results
Population-Based Analysis.
World
Neurosurg. 2021 May 5,
2021;151:e810-e820∟.
doi: 10.1016/j.wneu.2021.04.122∟.
PMID: 33964496∟.
Observational study. ˍ
Duc
NM.
The
impact of magnetic resonance imaging spectroscopy parameters on
differentiating
between paediatric medulloblastoma and ependymoma.
Contemp
Oncol (Pozn). 2021 May 6, 2021;25(2):95-99∟.
doi: 10.5114/wo.2021.105939∟.
PMID: 34667435∟.
Interventional study.
ˍ
Kudulaiti
N, Zhou Z, Luo C, Zhang J, Zhu F, Wu J.
A
nomogram for individualized prediction of overall survival in
patients with newly diagnosed glioblastoma: a real-world
retrospective cohort study.
BMC
Surg. 2021 May 6;21(1):238∟.
doi: 10.1186/s12893-021-01233-z∟.
PMID: 33957923∟.
Observational study. ˍ
*
Almengló
C, Caamaño P, Fraga M, Devesa J, Costoya JA, Arce VM.
From
neural stem cells to glioblastoma: A natural history of GBM
recapitulated in vitro.
J
Cell Physiol. 2021 May 7∟.
doi: 10.1002/jcp.30409∟.
PMID: 33959982∟.
Laboratory investigation. ˍ
*
Durgin
JS, Henderson F Jr, Nasrallah MP, Mohan S, Wang S, Lacey SF,
Melenhorst JJ, Desai AS, Lee JYK, Maus MV, June CH, Brem S,
O'Connor RS, Binder Z, O'Rourke DM.
Case
Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment
for Recurrent Glioblastoma.
Front
Oncol. 2021 May 7, 2021;11:669071∟.
doi: 10.3389/fonc.2021.669071∟.
PMID: 34026647∟.
Case report. ˍ
El-Khouly
FE, Veldhuijzen van Zanten SEM, Jansen MHA, Bakker DP, Sanchez
Aliaga E, Hendrikse NH, Vandertop WP, van Vuurden DG, Kaspers
GJL.
A
phase I/II study of bevacizumab, irinotecan and erlotinib in
children with progressive diffuse intrinsic pontine glioma.
J
Neurooncol. 2021 May 7∟.
doi: 10.1007/s11060-021-03763-1∟.
PMID: 33963476∟.
Interventional study. ˍ
Jiang
H, Yu K, Cui Y, Ren X, Li M, Yang C, Zhao X, Zhu Q, Lin
S.
Combination
of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas:
Results From a Prospective Study.
Front
Immunol. 2021 May 7, 2021;12:632547∟.
doi: 10.3389/fimmu.2021.632547∟.
PMID: 34025640∟.
Interventional study. ˍ
Vega-Moreno
DA, Santellán-Herández JO, Velázquez-Domínguez
HE, Martínez-Nava AO, Vicuña-González RM,
Mendoza-Trillo PR, Reyes-Rodríguez VA, Ibarra de la-Torre
A, González-González IE, Ochoa-Cacique D,
Sánchez-Mata R, Molina-Martinez RP, García-González
U.
Histopathological
correlation (WHO Classification) of meningiomas and their
anatomical localization. Multicenter epidemiological study in
Mexico.
World
Neurosurg. 2021 May 8, 2021;151:e888-e898∟.
doi: 10.1016/j.wneu.2021.05.003∟.
PMID: 33974982∟.
Observational study. ˍ
Bas
A, Valiyev E, Ozkan ND, Tombul I, Yonat S, Sayan M, Kurul IC.
A
Rare Entity: Primary Pulmonary Meningioma.
Turk
Patoloji Derg. 2021 May 10∟.
doi: 10.5146/tjpath.2021.01535∟.
PMID: 34514565∟.
Letter to the editor. ˍ
Compter
I, Verduin M, Shi Z, Woodruff HC, Smeenk RJ, Rozema T, Leijenaar
RTH, Monshouwer R, Eekers DBP, Hoeben A, Postma AA, Dekker A, De
Ruysscher D, Lambin P, Wee L.
Deciphering
the glioblastoma phenotype by computed tomography
radiomics.
Radiother
Oncol. 2021 May 10, 2021;160:132-139∟.
doi: 10.1016/j.radonc.2021.05.002∟.
PMID: 33984349∟.
Observational study. ˍ
*
Salmaggi
A, Corno C, Maschio M, Donzelli S, D'Urso A, Perego P, Ciusani
E.
Synergistic
Effect of Perampanel and Temozolomide in Human Glioma Cell
Lines.
J
Pers Med. 2021 May 10, 2021;11(5):390∟.
doi: 10.3390/jpm11050390∟.
PMID: 34068749∟.
Laboratory investigation. ˍ
Zamora
PL, Miller SR, Kovoor JJ.
Single
institution experience in re-irradiation of biopsy-proven diffuse
intrinsic pontine gliomas.
Childs
Nerv Syst. 2021 May 10∟.
doi: 10.1007/s00381-021-05195-8∟.
PMID: 33973056∟.
Observational study. ˍ
Shim
KY, Chung SW, Jeong JH, Hwang I, Park CK, Kim TM, Park SH, Won JK,
Lee JH, Lee ST, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH, Choi KS,
Choi SH.
Radiomics-based
neural network predicts recurrence patterns in glioblastoma using
dynamic susceptibility contrast-enhanced MRI.
Sci
Rep. 2021 May 11, 2021;11(1):9974∟.
doi: 10.1038/s41598-021-89218-z∟.
PMID: 33976264∟.
Observational study. ˍ
Ferroli
P, Vetrano IG, Schiavolin S, Acerbi F, Zattra CM, Schiariti M,
Leonardi M, Broggi M.
Brain
Tumor Resection in Elderly Patients: Potential Factors of
Postoperative Worsening in a Predictive Outcome Model.
Cancers
(Basel). 2021 May 12, 2021;13(10):2320∟.
doi: 10.3390/cancers13102320∟.
PMID: 34065990∟.
Observational study. ˍ
Huang
R, Wang T, Liao Z, Wang Z, Ye M, Zhou D, Xie H, Bai Y, Qiu Y, Liu
Y.
A
Observational study of the risk factors affecting recurrence time
in patients with recurrent glioblastoma.
Ann
Palliat Med. 2021 May 12, 2021;10(5):5391-5399∟.
doi: 10.21037/apm-21-823∟.
PMID: 34044551∟.
Observational study. ˍ
Sim
HW, McDonald KL, Lwin Z, Barnes EH, Rosenthal M, Foote MC, Koh ES,
Back M, Wheeler H, Sulman EP, Buckland ME, Fisher L, Leonard R,
Hall M, Ashley DM, Yip S, Simes J, Khasraw M.
A
randomized phase II trial of veliparib, radiotherapy and
temozolomide in patients with unmethylated MGMT glioblastoma: the
VERTU study.
Neuro
Oncol. 2021 May 13, 2021;23(10):1736–1749∟.
doi: 10.1093/neuonc/noab111∟.
PMID: 33984151∟.
Interventional study. ˍ
*
van
den Bent MJ, Tesileanu CMS, Wick W, Sanson M, Brandes AA, Clement
PM, Erridge S, Vogelbaum MA, Nowak AK, Baurain JF, Mason WP,
Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà
R, Weller M, McBain C, Reijneveld J, Enting RH, Caparrotti F,
Lesimple T, Clenton S, Gijtenbeek A, Lim E, Herrlinger U, Hau P,
Dhermain F, de Heer I, Aldape K, Jenkins RB, Dubbink HJ, Kros JM,
Wesseling P, Nuyens S, Golfinopoulos V, Gorlia T, French P,
Baumert BG.
Adjuvant
and concurrent temozolomide for 1p/19q non-co-deleted anaplastic
glioma (CATNON; EORTC study 26053-22054): second interim analysis
of a randomised, open-label, phase 3 study.
Lancet
Oncol. 2021 May 14, 2021;22(6):813-823∟.
doi: 10.1016/S1470-2045(21)00090-5∟.
PMID: 34000245∟.
Observational study. ˍ